: A Seaweed for Enhancing Immune and Cardiometabolic Health and Gut Microbiota Composition Modulation

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jul 14

PMID 37445955

Authors

Marion Guerrero-Wyss

Caroline Yans

Arturo Boscan-Gonzalez

Pablo Duran

Solange Parra-Soto

Lisse Angarita

Affiliations

Soon will be listed here.

Abstract

is the seaweed that is the most consumed by the Chilean population. It is recognized worldwide for its high nutritional value in protein, vitamins, minerals, and dietary fiber. This is a narrative review in which an extensive search of the literature was performed to establish the immunomodulator, cardiometabolic, and gut microbiota composition modulation effect of . Several studies have shown the potential of to function as prebiotics and to positively modulate the gut microbiota, which is related to anti-obesity, anti-inflammatory, anticancer, lipid-lowering, and hypoglycemic effects. The quantity of was negatively correlated with that of inflammatory monocytes and positively correlated with the levels of several gut metabolites. Seaweed-derived polysaccharides modulate the quantity and diversity of beneficial intestinal microbiota, decreasing phenol and p-cresol, which are related to intestinal diseases and the loss of intestinal function. Additionally, a beneficial metabolic effect related to this seaweed was observed, mainly promoting the decrease in the glycemic levels, lower cholesterol levels and cardiovascular risk. Consuming has a positive impact on the immune system, and its bioactive compounds provide beneficial effects on glycemic control and other metabolic parameters.

Citing Articles

Effect of Dietary Supplementation of Meal on Production and Meat Quality Traits of Lambs.

Quinones J, Huaquipan R, Diaz R, Perez Nunez I, Cortes M, Martinez A Animals (Basel). 2025; 15(2).

PMID: 39858206 PMC: 11758318. DOI: 10.3390/ani15020206.

Biomarkers and Seaweed-Based Nutritional Interventions in Metabolic Syndrome: A Comprehensive Review.

Valado A, Cunha M, Pereira L Mar Drugs. 2024; 22(12).

PMID: 39728125 PMC: 11677938. DOI: 10.3390/md22120550.

Impact of Novel Foods on the Human Gut Microbiome: Current Status.

Martinez A, Velazquez L, Diaz R, Huaiquipan R, Perez I, Munoz A Microorganisms. 2024; 12(9).

PMID: 39338424 PMC: 11433882. DOI: 10.3390/microorganisms12091750.

A study on the impact of diet supplementation of fermented dried seaweed powder (Kappaphycus alvarezii) on healthy cat gut performance, skin and hair coat conditions, and behaviour.

Mohamad Yusof L, Ahmad H, Hassim H, Mustaffa-Kamal F, Omar S, Zainundin N Vet Res Commun. 2024; 48(5):3061-3072.

PMID: 39052189 DOI: 10.1007/s11259-024-10479-w.

References

du Preez R, Magnusson M, Majzoub M, Thomas T, Praeger C, Glasson C . Brown Seaweed as an Intervention for Diet-Induced Obesity in Male Wistar Rats. Nutrients. 2021; 13(6). PMC: 8224310. DOI: 10.3390/nu13061754. View

Wang L, Ai C, Wen C, Qin Y, Liu Z, Wang L . Fucoidan isolated from Ascophyllum nodosum alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice. Food Funct. 2020; 11(6):5595-5606. DOI: 10.1039/d0fo00668h. View

Samuel V, Shulman G . The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016; 126(1):12-22. PMC: 4701542. DOI: 10.1172/JCI77812. View

Cherry P, OHara C, Magee P, McSorley E, Allsopp P . Risks and benefits of consuming edible seaweeds. Nutr Rev. 2019; 77(5):307-329. PMC: 6551690. DOI: 10.1093/nutrit/nuy066. View

Kishida R, Yamagishi K, Muraki I, Sata M, Tamakoshi A, Iso H . Frequency of Seaweed Intake and Its Association with Cardiovascular Disease Mortality: The JACC Study. J Atheroscler Thromb. 2020; 27(12):1340-1347. PMC: 7840157. DOI: 10.5551/jat.53447. View

Streppel M, Ocke M, Boshuizen H, Kok F, Kromhout D . Dietary fiber intake in relation to coronary heart disease and all-cause mortality over 40 y: the Zutphen Study. Am J Clin Nutr. 2008; 88(4):1119-25. DOI: 10.1093/ajcn/88.4.1119. View

Ejima R, Akiyama M, Sato H, Tomioka S, Yakabe K, Kimizuka T . Seaweed Dietary Fiber Sodium Alginate Suppresses the Migration of Colonic Inflammatory Monocytes and Diet-Induced Metabolic Syndrome via the Gut Microbiota. Nutrients. 2021; 13(8). PMC: 8401899. DOI: 10.3390/nu13082812. View

Cardoso S, Pereira O, Seca A, Pinto D, Silva A . Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods. Mar Drugs. 2015; 13(11):6838-65. PMC: 4663556. DOI: 10.3390/md13116838. View

Zhu Z, Han Y, Ding Y, Zhu B, Song S, Xiao H . Health effects of dietary sulfated polysaccharides from seafoods and their interaction with gut microbiota. Compr Rev Food Sci Food Saf. 2021; 20(3):2882-2913. DOI: 10.1111/1541-4337.12754. View

10.

Cherry P, Yadav S, Strain C, Allsopp P, McSorley E, Ross R . Prebiotics from Seaweeds: An Ocean of Opportunity?. Mar Drugs. 2019; 17(6). PMC: 6627129. DOI: 10.3390/md17060327. View

11.

Apostolova E, Lukova P, Baldzhieva A, Katsarov P, Nikolova M, Iliev I . Immunomodulatory and Anti-Inflammatory Effects of Fucoidan: A Review. Polymers (Basel). 2020; 12(10). PMC: 7602053. DOI: 10.3390/polym12102338. View

12.

Su F, Song Q, Zhang C, Xu X, Li M, Yao D . A β-1,3/1,6-glucan from Durvillaea Antarctica inhibits tumor progression in vivo as an immune stimulator. Carbohydr Polym. 2019; 222:114993. DOI: 10.1016/j.carbpol.2019.114993. View

13.

Lopez-Lopez I, Bastida S, Ruiz-Capillas C, Bravo L, Larrea M, Sanchez-Muniz F . Composition and antioxidant capacity of low-salt meat emulsion model systems containing edible seaweeds. Meat Sci. 2010; 83(3):492-8. DOI: 10.1016/j.meatsci.2009.06.031. View

14.

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

15.

Cheng Y, Sibusiso L, Hou L, Jiang H, Chen P, Zhang X . Sargassum fusiforme fucoidan modifies the gut microbiota during alleviation of streptozotocin-induced hyperglycemia in mice. Int J Biol Macromol. 2019; 131:1162-1170. DOI: 10.1016/j.ijbiomac.2019.04.040. View

16.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

17.

Gabbia D, De Martin S . Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases. Molecules. 2020; 25(18). PMC: 7570850. DOI: 10.3390/molecules25184182. View

18.

Reilly P, ODoherty J, Pierce K, Callan J, OSullivan J, Sweeney T . The effects of seaweed extract inclusion on gut morphology, selected intestinal microbiota, nutrient digestibility, volatile fatty acid concentrations and the immune status of the weaned pig. Animal. 2012; 2(10):1465-73. DOI: 10.1017/S1751731108002711. View

19.

Lecomte V, Kaakoush N, Maloney C, Raipuria M, Huinao K, Mitchell H . Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One. 2015; 10(5):e0126931. PMC: 4436290. DOI: 10.1371/journal.pone.0126931. View

20.

Robertson S, Zhou J, Geddes K, Rubino S, Cho J, Girardin S . Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes. 2013; 4(3):222-31. PMC: 3669167. DOI: 10.4161/gmic.24373. View